Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18431256 | Automated Needle Entry Detection | February 2024 | January 2025 | Allow | 11 | 0 | 0 | No | No |
| 18288073 | ULTRASOUND-GUIDED PREDICTION OF LOCAL BOLUS VELOCITIES | October 2023 | October 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18360626 | Systems and Methods of Determining Dimensions of Structures in Medical Images | July 2023 | September 2025 | Allow | 26 | 1 | 1 | Yes | No |
| 18351101 | ENERGY DELIVERY DEVICE AND METHODS OF USE | July 2023 | September 2024 | Allow | 14 | 1 | 0 | Yes | No |
| 18034713 | MACHINE LEARNING SYSTEM FOR X-RAY BASED IMAGING CAPSULE | May 2023 | January 2026 | Abandon | 32 | 1 | 0 | No | No |
| 18138398 | Methods and Devices for Color Detection to Localize the Blood Mass of an Intracerebral Hematoma | April 2023 | January 2024 | Allow | 9 | 0 | 0 | No | No |
| 18193191 | METHOD, SYSTEM AND APPARATUS FOR IMAGE-GUIDED INSERTION OF IMPLANT DEVICES | March 2023 | August 2024 | Allow | 16 | 1 | 0 | Yes | No |
| 18190443 | SENSOR DEVICE | March 2023 | December 2025 | Abandon | 32 | 2 | 0 | Yes | No |
| 18123462 | OPTICAL SYSTEM FOR BREAST X-RAY COMPUTED TOMOGRAPHY | March 2023 | September 2024 | Abandon | 18 | 2 | 0 | No | No |
| 17999526 | ULTRASOUND-BASED INTRAVASCULAR PLACEMENT GUIDE STRUCTURE | November 2022 | December 2024 | Allow | 25 | 1 | 0 | No | No |
| 17986721 | THERAPEUTIC INHIBITION AND STIMULATION WITH TRANSCRANIAL ULTRASOUND | November 2022 | April 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17923401 | BIOLOGICAL EXAMINATION DEVICE AND BIOLOGICAL INFORMATION ANALYSIS METHOD | November 2022 | March 2025 | Allow | 28 | 1 | 0 | Yes | No |
| 18047346 | ULTRASOUND CREDENTIALING SYSTEM | October 2022 | February 2024 | Allow | 16 | 1 | 1 | Yes | No |
| 17883667 | Tracking Apparatus For Tracking A Patient Limb | August 2022 | December 2025 | Allow | 40 | 2 | 0 | Yes | No |
| 17878562 | CONSTANT FORCE ULTRASOUND PROBE HANDLE | August 2022 | October 2024 | Allow | 27 | 1 | 0 | No | No |
| 17805904 | Left Atrial Appendage Closure Guidance in Medical Imaging | June 2022 | May 2024 | Allow | 24 | 2 | 1 | Yes | No |
| 17751514 | MEDICAL NEEDLE GUIDANCE SYSTEM | May 2022 | August 2025 | Abandon | 39 | 1 | 1 | No | No |
| 17479253 | METHOD FOR ACTUATING AN IMAGING DEVICE FOR ACQUIRING A CONTRAST AGENT-ENHANCED IMAGE DATA SET | September 2021 | February 2026 | Allow | 52 | 4 | 0 | Yes | No |
| 17386775 | RAPID QUANTITATIVE EVALUATIONS OF HEART FUNCTION WITH STRAIN MEASUREMENTS FROM MRI | July 2021 | August 2024 | Allow | 37 | 2 | 1 | Yes | No |
| 17354040 | BIOLOGICAL INFORMATION MEASURING APPARATUS AND ELECTRONIC DEVICE INCLUDING THE SAME | June 2021 | November 2024 | Abandon | 40 | 2 | 0 | Yes | No |
| 17351689 | SURGICAL SYSTEM HAVING ASSISTED NAVIGATION | June 2021 | September 2024 | Allow | 39 | 2 | 1 | Yes | No |
| 17304245 | REAL-TIME ANATOMICALLY BASED DEFORMATION MAPPING AND CORRECTION | June 2021 | August 2024 | Allow | 38 | 1 | 0 | Yes | No |
| 17349030 | ULTRASONIC IMAGING SYSTEM AND BLOOD FLOW IMAGING METHOD | June 2021 | August 2024 | Allow | 38 | 2 | 0 | Yes | No |
| 17327140 | FAILURE DETERMINATION APPARATUS OF ULTRASOUND DIAGNOSIS APPARATUS, FAILURE DETERMINATION METHOD, AND STORAGE MEDIUM | May 2021 | November 2024 | Allow | 42 | 3 | 0 | Yes | No |
| 17294699 | DIFFUSION MAGNETIC RESONANCE IMAGING USING SPHERICAL NEURAL NETWORKS | May 2021 | September 2024 | Allow | 40 | 3 | 0 | Yes | No |
| 17285124 | DEEP LEARNING-BASED ULTRASOUND IMAGING GUIDANCE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | April 2021 | November 2024 | Allow | 43 | 3 | 0 | Yes | No |
| 17281195 | METHOD AND SYSTEM FOR SPECTRAL ANALYSIS AND DETERMINATION OF A MARKER MAKING IT POSSIBLE TO ENSURE THE SAFETY OF THERAPEUTIC ULTRASOUND INTERVENTIONS | March 2021 | January 2026 | Allow | 58 | 4 | 0 | Yes | No |
| 17209891 | ROBOTICALLY-ASSISTED SURGICAL DEVICE, ROBOTICALLY-ASSISTED SURGICAL METHOD, AND SYSTEM | March 2021 | November 2024 | Abandon | 44 | 1 | 0 | No | No |
| 17133512 | ULTRASOUND TRANSDUCER ARRAY WITH SEPARATED ACOUSTIC AND ELECTRIC MODULE | December 2020 | October 2024 | Allow | 45 | 3 | 0 | Yes | No |
| 17129815 | METHOD AND SYSTEM FOR EXTRACTING LOWER LIMB VASCULATURE | December 2020 | December 2023 | Abandon | 36 | 2 | 0 | No | No |
| 17127877 | METHOD FOR MONITORING A HEALTH PARAMETER OF A PERSON THAT INVOLVES PRODUCING A PULSE WAVE SIGNAL FROM RADIO FREQUENCY SCANNING | December 2020 | September 2024 | Abandon | 45 | 2 | 0 | No | No |
| 17095121 | METHODS FOR SURGICAL GUIDANCE IN BREAST CANCER SURGERY AND LYMPH NODE DISSECTION USING TWO OR MORE IMPLANTATION DEVICES COMPRISING A CAPSULE AND A POPULATION OF ULTRASOUND-SWITCHABLE FLUOROPHORES INCORPORATED IN THE CAPSULE | November 2020 | August 2023 | Allow | 33 | 2 | 0 | Yes | No |
| 17089437 | SYSTEMS AND METHODS FOR IMAGING A BODY REGION USING IMPLANTED MARKERS | November 2020 | August 2024 | Allow | 45 | 4 | 1 | Yes | No |
| 17051275 | SYSTEM AND METHOD FOR REMOTE MONITORING | October 2020 | March 2024 | Allow | 40 | 1 | 0 | Yes | No |
| 17072713 | MAGNETIC RESONANCE IMAGING SYSTEM AND POSITION DISPLAY METHOD | October 2020 | September 2024 | Abandon | 47 | 4 | 0 | No | No |
| 17066473 | System of Determining the Correct Implantable Collamer Lens Size from Ultrasound Images of the Eye | October 2020 | July 2024 | Allow | 45 | 4 | 0 | Yes | No |
| 16928662 | Human Body Measurement Using Thermographic Images | July 2020 | August 2023 | Allow | 38 | 2 | 1 | Yes | No |
| 16927118 | ARTIFICIAL INTELLIGENCE ULTRASOUND-MEDICAL-DIAGNOSIS APPARATUS USING SEMANTIC SEGMENTATION AND REMOTE MEDICAL-DIAGNOSIS METHOD USING THE SAME | July 2020 | February 2024 | Allow | 43 | 2 | 1 | Yes | No |
| 16896475 | ATTACHMENT AND ULTRASOUND PROBE | June 2020 | December 2023 | Abandon | 43 | 4 | 0 | Yes | No |
| 16771165 | DEVICE AND METHOD FOR SECURING A TRANSDUCER IN POSITION | June 2020 | September 2023 | Allow | 40 | 3 | 0 | Yes | No |
| 16847211 | REDUNDANT RECIPROCAL TRACKING SYSTEM | April 2020 | January 2026 | Abandon | 60 | 8 | 0 | Yes | No |
| 16819128 | SYSTEMS AND METHODS FOR DETERMINING COUCH POSITION | March 2020 | March 2024 | Allow | 48 | 4 | 0 | No | No |
| 16812028 | VIDEOSTROBOSCOPY OF VOCAL CORDS WITH A HYPERSPECTRAL, FLUORESCENCE, AND LASER MAPPING IMAGING SYSTEM | March 2020 | March 2025 | Allow | 60 | 3 | 0 | Yes | No |
| 16739721 | BIOMETRIC SIGNAL MEASURING DEVICE | January 2020 | December 2023 | Abandon | 48 | 4 | 0 | Yes | No |
| 16622005 | CAVITATION-ENHANCED TARGETED DRUG DELIVERY AND DOSING | December 2019 | November 2023 | Allow | 47 | 2 | 0 | Yes | No |
| 16676285 | METHODS AND SYSTEMS FOR BODY CONTOUR PROFILES | November 2019 | May 2024 | Abandon | 54 | 4 | 1 | No | No |
| 16598393 | MULTI-PARAMETRIC WEIGHTED MULTI-BED PET ACQUISITION AND RECONSTRUCTION | October 2019 | April 2025 | Abandon | 60 | 6 | 1 | No | No |
| 16580151 | 3D INTRACARDIAC ACTIVITY PRESENTATION | September 2019 | January 2025 | Allow | 60 | 6 | 0 | Yes | No |
| 16358790 | ANALYSIS METHOD AND ANALYSIS UNIT FOR DETERMINING RADIOLOGICAL RESULT DATA | March 2019 | October 2023 | Allow | 55 | 4 | 0 | Yes | No |
| 16246522 | DOPPLER GUIDED ULTRASOUND THERAPY | January 2019 | March 2025 | Allow | 60 | 5 | 0 | Yes | Yes |
| 16210253 | AUTOMATED NEEDLE ENTRY DETECTION | December 2018 | October 2023 | Allow | 58 | 5 | 1 | Yes | No |
| 16140709 | TUBULAR BODY STRUCTURE IMAGING AND LOCATING SYSTEM | September 2018 | September 2024 | Allow | 60 | 7 | 0 | Yes | No |
| 16139625 | ADHESIVE HYDROPHILIC PAD FOR ULTRASOUND TRANSDUCER | September 2018 | February 2025 | Abandon | 60 | 3 | 1 | Yes | Yes |
| 16132630 | ULTRASOUND FOCUSING UTILIZING A 3D-PRINTED SKULL REPLICA | September 2018 | May 2024 | Abandon | 60 | 5 | 0 | Yes | Yes |
| 15985402 | Intraosseous and Intramedullary Visualization | May 2018 | October 2024 | Allow | 60 | 6 | 0 | Yes | No |
| 15579037 | SYSTEM, METHOD, COMPUTER-ACCESSIBLE MEDIUM AND APPARATUS FOR FAST RADIOACTIVE SEED LOCALIZATION IN INTRAOPERATIVE CONE BEAM CT FOR LOW-DOSE-RATE PROSTATE BRACHYTHERAPY | December 2017 | April 2024 | Abandon | 60 | 4 | 1 | No | No |
| 15718578 | ULTRASONIC DIAGNOSTIC APPARATUS | September 2017 | February 2024 | Abandon | 60 | 6 | 1 | Yes | No |
| 15674380 | ENT Image Registration | August 2017 | January 2024 | Allow | 60 | 4 | 1 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ASGHAR, AMINAH.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner ASGHAR, AMINAH works in Art Unit 3797 and has examined 41 patent applications in our dataset. With an allowance rate of 65.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 47 months.
Examiner ASGHAR, AMINAH's allowance rate of 65.9% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by ASGHAR, AMINAH receive 3.56 office actions before reaching final disposition. This places the examiner in the 95% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ASGHAR, AMINAH is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +66.3% benefit to allowance rate for applications examined by ASGHAR, AMINAH. This interview benefit is in the 98% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 20.6% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 4.9% of cases where such amendments are filed. This entry rate is in the 5% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 21% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 80.0% are granted (fully or in part). This grant rate is in the 85% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.